Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Victoria Furer, Christien Rondaan, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette de Thurah, Ulf Mueller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico M Wulffraat, Ori Elkayam

10.1136/rmdopen-2021-001594

February 24, 2021

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, Natalia B Amaral, Pamella Indira Menezes, Saulo Musse Dib, Samara Libich Gigante, Maira N Benatti, Uebe C Rezek, Laerte L Emrich-Filho, Betania A A Sousa, Sergio C L Almeida, Rodrigo Luppino Assad, Flavio P Veras, Ayda Schneider, Tamara S Rodrigues, Luiz O S Leiria, Larissa D Cunha, Jose C Alves-Filho, Thiago M Cunha, Eurico Arruda, Carlos H Miranda, Antonio Pazin-Filho, Maria Auxiliadora-Martins, Marcos C Borges, Benedito A L Fonseca, Valdes R Bollela, Cristina M Del-Ben, Fernando Q Cunha, Dario S Zamboni, Rodrigo C Santana, Fernando C Vilar, Paulo Louzada-Junior, Rene D R Oliveira

10.1136/rmdopen-2020-001455

February 4, 2021

Evidences for a protective role of vitamin D in COVID-19

Maurizio Cutolo, Sabrina Paolino, Vanessa Smith

10.1136/rmdopen-2020-001454

December 28, 2020

Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey

Francesco Ursini, Jacopo Ciaffi, Luana Mancarella, Lucia Lisi, Veronica Brusi, Carlotta Cavallari, Martina D’Onghia, Anna Mari, Elena Borlandelli, Jacopo Faranda Cordella, Micaela La Regina, Pasquale Viola, Piero Ruscitti, Marco Miceli, Roberto De Giorgio, Nicola Baldini, Claudio Borghi, Alessandro Gasbarrini, Annamaria Iagnocco, Roberto Giacomelli, Cesare Faldini, Maria Paola Landini, Riccardo Meliconi

10.1136/rmdopen-2021-001735

August 23, 2021

Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study

Philip J Mease, Robert Landewé, Proton Rahman, Hasan Tahir, Atul Singhal, Elke Boettcher, Sandra Navarra, Aimee Readie, Shephard Mpofu, Eumorphia Maria Delicha, Luminita Pricop, Desirée van der Heijde

10.1136/rmdopen-2021-001600

July 30, 2021

Exercise, infection and rheumatic diseases: what do we know?

Leonard Calabrese, David C Neiman

10.1136/rmdopen-2021-001644

May 17, 2021

Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review

Muhanad Taha, Lobelia Samavati

10.1136/rmdopen-2021-001580

May 6, 2021

Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis

Nazariy Koval, Mariana Alves, Rui Plácido, Ana G Almeida, João Eurico Fonseca, Joaquim J Ferreira, Fausto J Pinto, Daniel Caldeira

10.1136/rmdopen-2021-001678

July 12, 2021

Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3

Daniel Aletaha, René Westhovens, Cecile Gaujoux-Viala, Giovanni Adami, Alan Matsumoto, Paul Bird, Osvaldo Daniel Messina, Maya H Buch, Beatrix Bartok, Zhaoyu Yin, Ying Guo, Thijs Hendrikx, Gerd R Burmester

10.1136/rmdopen-2021-001621

August 12, 2021

Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changes

Elisabeth Gjefsen, Kristina Gervin, Guro Goll, Lars Christian Haugli Bråten, Monica Wigemyr, Hans Christian D Aass, Maria Dehli Vigeland, Elina Schistad, Linda Margareth Pedersen, Are Hugo Pripp, Kjersti Storheim, Kaja Kristine Selmer, John Anker Zwart

10.1136/rmdopen-2021-001726

August 3, 2021

Most Read Articles